Heron Therapeutics Cash Flow Statement (2010-2026) | HRTX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-60.47M-51.71M-53.54M-62.92M-49.50M-41.88M-20.36M-33.06M-42.40M-24.93M-10.22M-4.80M-6.45M-4.46M4.17M3.15M-1.64M-4.09M0.04M-4.76M
Share-based Compensation (Quarter)
11.24M11.24M12.89M10.91M10.35M11.20M10.51M7.95M13.90M6.68M4.32M3.38M4.57M2.72M2.29M2.51M2.80M2.85M2.18M2.98M
Gains from Investment Securities (Quarter)
0.88M1.17M18.94M0.07M20.37M20.50M21.38M11.69M5,548.98M0.03M29.38M3.58M7.70M26.08M0.03M6.06M3.15M28.70M0.22M
Asset Writedowns and Impairment (Quarter)
0.11M0.16M0.12M0.05M0.04M0.04M0.08M0.15M0.15M0.15M0.15M0.17M3.27M0.83M
Non-cash Items (Quarter)
12.24M11.39M1.50M0.50M
Cash from Operations (Quarter)
-62.99M-53.17M-45.26M-43.94M-28.37M-37.07M-37.53M-24.90M-27.16M-9.18M2.46M-9.52M-4.60M3.37M-11.78M-8.87M-10.87M1.33M-9.18M-1.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.30M-0.04M1.01M-0.10M0.01M0.26M0.57M0.47M-0.37M0.04M1.72M0.64M0.10M0.20M0.25M0.21M0.20M0.20M0.24M0.14M
Amortization of Deferred Charges (Quarter)
0.02M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.10M0.05M0.05M0.10M0.10M0.05M0.05M0.10M-0.04M
Depreciation & Amortization (CF) (Quarter)
0.73M0.75M0.79M0.72M0.67M0.71M0.79M0.72M0.74M0.73M0.72M0.69M0.64M0.58M0.58M0.55M0.61M0.61M0.54M0.53M
Change in Working Capital
Change in Receivables (Quarter)
4.09M0.47M-7.59M5.60M-0.80M1.89M9.86M-0.60M25.25M-12.90M-3.66M5.18M8.39M-6.67M11.84M-0.14M1.20M1.12M8.54M-5.89M
Change in Inventory (Quarter)
0.17M-1.30M6.88M8.09M4.85M-9.08M2.33M-2.51M-7.44M-2.62M0.10M0.36M0.39M3.09M7.21M3.77M16.03M-2.94M14.19M0.17M
Change in Account Payables (Quarter)
9.55M-5.36M-2.08M4.42M5.58M-7.26M-3.32M0.84M-2.11M-0.10M1.38M-2.40M9.39M-0.04M1.52M0.62M-0.30M-0.02M-3.02M-0.02M
Change in Accured Expenses (Quarter)
4.05M2.33M-0.74M-3.05M4.11M-1.61M13.45M-3.91M0.35M0.52M-1.15M-1.58M2.08M-1.20M0.79M-3.10M7.64M2.51M3.55M-2.88M
Other Working Capital Changes (Quarter)
-0.94M3.91M2.69M0.41M-4.50M-1.63M4.72M-0.91M-9.46M-0.17M-4.88M0.22M-0.29M3.84M6.16M8.60M-9.30M5.25M-5.43M-1.12M
Investing Activities
Capital Expenditures (Quarter)
0.32M1.53M0.39M1.04M0.32M0.04M0.41M0.22M0.28M0.79M0.25M0.43M0.64M0.11M0.21M0.39M
Sales of Property, Plant and Equipment (Quarter)
0.06M0.17M0.00M0.04M0.01M0.03M0.02M
Change in Acquisitions & Divestments (Quarter)
58.00M52.44M14.00M49.96M41.00M32.00M21.00M51.00M27.93M13.50M14.75M39.17M29.89M30.05M24.37M25.24M16.72M17.96M7.10M12.59M
Cash from Investing Activities (Quarter)
39.70M21.63M-24.26M10.95M19.76M-36.05M2.02M36.83M13.22M-23.22M-8.84M1.28M2.05M3.97M11.42M2.27M7.33M11.86M-5.46M-0.94M
Financing Activities
Other financing activities (Quarter)
4.22M-0.05M-0.12M-0.64M-0.46M-0.22M-0.21M-0.21M-0.39M-0.31M-0.00M0.01M0.32M0.01M-0.04M0.06M0.19M-0.05M-1.37M-0.05M
Cash from Financing Activities (Quarter)
154.73M-0.07M0.49M-0.64M0.32M74.94M0.44M-0.21M0.32M53.80M0.20M0.01M0.49M0.01M0.42M0.06M0.78M13.36M0.22M-0.05M
Additional items
Change in Cash (Quarter)
131.43M-31.60M-69.03M-33.63M-8.30M1.83M-35.07M11.73M-13.63M21.40M-6.18M-8.23M-2.06M7.36M0.06M-6.53M-2.75M26.55M-14.42M-2.53M
Free Cash Flow (Quarter)
-63.31M-54.70M-45.65M-44.98M-28.70M-37.11M-37.95M-25.12M-27.44M-9.97M2.21M-9.52M-4.60M2.94M-12.42M-8.98M-11.08M1.33M-9.18M-1.93M
Net Cash Flow (Quarter)
131.43M-31.60M-69.03M-33.63M-8.30M1.83M-35.07M11.73M-13.63M21.40M-6.18M-8.23M-2.06M7.36M0.06M-6.53M-2.75M26.55M-14.42M-2.53M